Risk of solid cancer in patients with mast cell activation syndrome: Results from Germany and USA.

Molderings, Gerhard J; Zienkiewicz, Thomas; Homann, Jürgen; Menzen, Markus; Afrin, Lawrence B

Molderings, Gerhard J; Zienkiewicz, Thomas; Homann, Jürgen; Menzen, Markus; Afrin, Lawrence B.

Afiliação

Molderings GJ; Institute of Human Genetics, University Hospital of Bonn, Bonn, D-53127, Germany.
Zienkiewicz T; Institute of Pathology Bonn-Duisdorf, Bonn, D-53123, Germany.
Homann J; Division of Internal Medicine, Department of Gastroenterology and Diabetology, Gemeinschaftskrankenhaus Bonn, Bonn, D-53113, Germany.
Menzen M; Division of Internal Medicine, Department of Gastroenterology and Diabetology, Gemeinschaftskrankenhaus Bonn, Bonn, D-53113, Germany.
Afrin LB; Armonk Integrative Medicine, Armonk, NY, 10504, USA.

F1000Res ; 6: 1889, 2017.

Article em En | MEDLINE | ID: mdl-29225779

Palavras-chave

breast cancer; cancer; cervical carcinoma; mast cell; melanoma; systemic mast cell activation disease; systemic mast cell activation syndrome; systemic mastocytosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article